CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-01 | Gridley Adam President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −300,000 | 0 | ||
| 2018-10-01 | Gridley Adam President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2018-10-01 | Gridley Adam President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2018-07-31 | Kelley Lynne E Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-06-15 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-06-15 | Lewis Michael Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-06-15 | RAKIN KEVIN Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-06-15 | Kong Garheng Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-06-15 | Baltzell Joshua J Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-06-15 | JOHNSON JOHN Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-05-16 | Gridley Adam President and CEO | Purchase | +2,000 | $2.15 | $4K | 7,000 |
| 2018-04-16 | Washer Susan B. Director | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-02-16 | Kennedy Stephen Richard Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2018-02-16 | Lieber Jonathan I Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2018-02-16 | Haut Donald Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2018-02-16 | Gridley Adam See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2017-10-10 | Kennedy Stephen Richard EVP and COO | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2017-08-16 | GILL DAVID N Director | Purchase | +3,000 | $1.81 | $5K | 14,000 |
| 2017-06-13 | Lewis Michael Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-13 | RAKIN KEVIN Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 20 of 27 · 525 trades